No­vo Hold­ings, Vi­vo lead a record $200M raise for a Sin­ga­pore-based tools play­er with plans for a Boston hub, new deals

Close to a year af­ter putting a foot down in Sin­ga­pore, No­vo Hold­ings has spot­ted an Asia-based play­er worth bet­ting a big chunk of its “pa­tient cap­i­tal” on.

The Dan­ish group is co-lead­ing a $200 mil­lion Se­ries A for Es­co Life­sciences Group — set­ting a new record for life sci­ences tools com­pa­nies in the re­gion, ac­cord­ing to the in­vestor, and fund­ing a sprint to­ward “Es­co 3.0,” where cell and gene ther­a­py process de­vel­op­ment and man­u­fac­tur­ing will loom large.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER